Neurol. praxi. 2018;19(1):53-58 | DOI: 10.36290/neu.2019.073

Application of determination of free light chains of immunoglobulins in the diagnosis of multiple sclerosis

Mgr. Ľubica Jesenská1, MUDr. Daniel Čierny, PhD.1, MUDr. Lenka Plicová1, prof. MUDr. Dušan Dobrota, CSc.2
1 Ústav klinickej biochémie Univerzitnej nemocnice Martin a Jesseniovej LF UK, Martin
2 Ústav lekárskej biochémie Jesseniovej LF UK, Martin

This work gives a brief review of the markers used in the laboratory diagnosis of multiple sclerosis. We focus on the determinationof free light chains of immunoglobulins and its possible application in the process of diagnosis of multiple sclerosis.

Keywords: multiple sclerosis, diagnosis, cerebrospinal fluid, free light chains

Received: October 10, 2019; Accepted: October 21, 2019; Prepublished online: October 21, 2019; Published: March 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Jesenská Ľ, Čierny D, Plicová L, Dobrota D. Application of determination of free light chains of immunoglobulins in the diagnosis of multiple sclerosis. Neurol. praxi. 2018;19(1):53-58. doi: 10.36290/neu.2019.073.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bradwell AR. Serum free light chain analysis. 6th edition. The Binding Site ltd., Binmingham: UK 2010; ISBN: 9780704427969.
    2. Compston A, Coles A. Multiple sclerosis. Lancet 2008; 372(9648): 1502-1517. Go to original source...
    3. Fischer Ch, Arneth B, Koehler J, Lotz J, Lackner KJ. Kappa free light chains in cerebrospinal fluid as markers of intrathecal immunoglobulin synthesis. Clinical Chemistry 2004; 50(10): 1809-1813. Go to original source...
    4. Freedman MS, Thompson EJ, Deisenhammer F, Giovannoni G, Grimsley G, Keir G, Öhman S, Racke MK, Sharief M, Sindic CJM, Sellebjerg F, Tourtellotte WW. Recommendeted standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis. Archives of neurology 2005; 62: 865-870. Go to original source... Go to PubMed...
    5. Gaško R, Klímová E, Balla J. Biochemické vyšetrenie mozgovomiechového moku - doporučenie pri diagnostike sclerosis multiplex, revízia 2008. Laboratórna diagnostika 2009; 1-2: 131-133.
    6. Havrdová E. Roztroušená skleróza 2013; ISBN 978-80-204-3154-7.
    7. Hassan-Smith G, Durant L, Tsentemeidou A, Assi KL, Faint JM, Kalra S, Douglas MR, Cumow SJ. High sensitivity and specificity of elevated cerebrospinal fluid kappa free light chains in suspected multiple sclerosis. J Neuroimmunol 2014; 276: 175-179. Go to original source... Go to PubMed...
    8. Jacob S, Karim A, Drayson M, Mitchell J. PATH58 Kappa and lambda free light chains in CSF in the differential diagnosis of multiple sclerosis and its correlation with clinical subtypes. J Neurol Neurosurg Psychiatry 2010; 81: e23 doi:10.1136/jnnp.2010.226340.26. Go to original source...
    9. Kaplan B, Aizenbud BM, Golderman S, Yaskeriev R, Sela BA. Free light chainmonomers in the diagnosis of multiple sclerosis. J Neuroimmunol 2010; 229: 263-271. Go to original source... Go to PubMed...
    10. Katsavos S, Anagnostouli M. Biomarkers in multiple sclerosis: An up-to-date Overview. Hindawi Puplishing Corporation, Multiple sclerosis international 2013: ID340508. Go to original source...
    11. Keblich P, Adam P, Sobek O, Koudelková M, Procházka J, Hanuljaková E, Tomaškovič M, Doležil D, Adam D, Hybeľová M. Význam základního vyšetření likvoru pro diagnostiku postižení. Labor Aktuell 2009; 1: 10-14.
    12. Klímová E. Sclerosis multiplex - informácie pre prax 2006. Via practica 2006; 3(5): 249-255.
    13. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, Van den Noort S, Weinshenker BY, Wolinsky JS. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127. Go to original source... Go to PubMed...
    14. Piťha J. Diagnostický algoritmus roztroušené sklerózy. Neurol. praxi 2013; 14: 6-8.
    15. Polman ChH, Reingold SC, Banwell B, Clanet M, Jeffrey AC, Filipi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Conor P, Sandberg M, Thomson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the mcDonald Criteria. Ann Neurology 2011; 69: 292-302. Go to original source... Go to PubMed...
    16. Presslauer S, Milosavljevic D, Huebl W, Parigger S, Schneider-Koch G, Bruecke T. Kappa free light chains: diagnostic and prognostic relevance in MS and CIS. PLoS ONE 2014; 9(2): e89945. Go to original source... Go to PubMed...
    17. Senel M, Tumani H, Lauda F, Presslauder S, Mojib-Yezdani R, Otto M, Brettschneider J. Cerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosis. Plos One 2014; 9(4): e88680. Go to original source... Go to PubMed...
    18. Sobek O, Adam P, Koudelková M, Štourač P, Mareš J. Algoritmus vyšetření likvoru v návaznosti na doporučení Sekce neuroimunologie a likvorologie České neurologické společnosti JEP. Cesk Slov neurol N 2012; 75/108(2): 159-163.
    19. Villar LM, Espino M, Costa-Frossard L, Muriel A, Jimenez J, Alvarez-Cermeno JC. High levels of cerebrospinal fluid free kappa chains predict conversion to multiple sclerosis. Clinica Chimika Acta 2012; 413: 1813-1816. Go to original source...
    20. Zeman D, Kušnierová P, Bartoš V, Hradílek P, Kurková B, Zapletalová O. Quantitation of free light chains in the cerebrospinal fluid reliably predicts their intrathecal synthesis. Ann Clin Biochem 2016; 53: 174-176. Go to original source...

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.